Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syndax Pharma (NQ: SNDX ) 18.82 +0.13 (+0.70%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Syndax Pharma < Previous 1 2 3 4 Next > Last Week's Notable Insider Buys: AppLovin, Bed Bath And Beyond, TuSimple And More April 25, 2021 Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders took advantage of recent public... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 22, 2021 Gainers Renalytix AI (NASDAQ:RNLX) shares rose 21.41% to $30.62 during Thursday's regular session. Renalytix AI's stock is trading at a volume of 1.0 million... Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence 46 Biggest Movers From Yesterday April 21, 2021 Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it... Via Benzinga Why Syndax Pharmaceuticals Stock Is Sinking Today April 20, 2021 The company announced results from an early-stage clinical study. Via The Motley Fool Mid-Afternoon Market Update: Dow Tumbles 370 Points; Kansas City Southern Shares Spike Higher April 20, 2021 Toward the end of trading Tuesday, the Dow traded down 1.09% to 33,706 while the NASDAQ fell 1.30% to 13,733.94. The S&P also fell, dropping 0.97% to 4,122.80. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session April 20, 2021 Gainers MyMD Pharmaceuticals, Inc. - Common Stock (NASDAQ:MYMD) shares moved upwards by 14.12% to $5.1 during Tuesday's regular session. As of 12:31 EST, this security... Via Benzinga Mid-Day Market Update: Crude Oil Down 1.8%; Futu Holdings Shares Plunge April 20, 2021 Midway through trading Tuesday, the Dow traded down 0.68% to 33,846.89 while the NASDAQ fell 0.91% to 13,788.71. The S&P also fell, dropping 0.65% to 4,136.13. The U.S. has... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 31 Stocks Moving In Tuesday's Mid-Day Session April 20, 2021 Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) gained 20.8% to $5.32 after dropping more than 10% on Monday. Takung Art Co., Ltd. (NASDAQ: TKAT) shares surged 18.2% to $21.08... Via Benzinga Mid-Morning Market Update: Markets Open Lower; P&G Profit Tops Views April 20, 2021 Following the market opening Tuesday, the Dow traded down 0.43% to 33,931.13 while the NASDAQ fell 0.22% to 13,883.52. The S&P also fell, dropping 0.27% to 4,151.87. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Why Crispr, KalVista And Syndax Are Moving Today April 20, 2021 CRISPR Therapeutics AG (NASDAQ: CRSP), Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) and KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) were among the early movers in the biopharma... Via Benzinga The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex April 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,... Via Benzinga The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs April 17, 2021 The FDA and CDC announced their recommendation to pause the use of Johnson & Johnson's JNJ COVID-19 vaccine following incidences of severe clots. J&J's pain turned into gains for other COVID-19 vaccine... Via Talk Markets Exposures COVID-19 Product Safety The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs April 17, 2021 Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American... Via Benzinga The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs April 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.